IE55519B1 - Use of a protoberberine alkaloid and composition containing same - Google Patents

Use of a protoberberine alkaloid and composition containing same

Info

Publication number
IE55519B1
IE55519B1 IE1098/83A IE109883A IE55519B1 IE 55519 B1 IE55519 B1 IE 55519B1 IE 1098/83 A IE1098/83 A IE 1098/83A IE 109883 A IE109883 A IE 109883A IE 55519 B1 IE55519 B1 IE 55519B1
Authority
IE
Ireland
Prior art keywords
berberine
represents hydrogen
compounds
protoberberine
methyl
Prior art date
Application number
IE1098/83A
Other languages
English (en)
Other versions
IE831098L (en
Original Assignee
Maroko Peter R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maroko Peter R filed Critical Maroko Peter R
Publication of IE831098L publication Critical patent/IE831098L/xx
Publication of IE55519B1 publication Critical patent/IE55519B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IE1098/83A 1982-05-14 1983-05-12 Use of a protoberberine alkaloid and composition containing same IE55519B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37812282A 1982-05-14 1982-05-14
US40988382A 1982-08-20 1982-08-20

Publications (2)

Publication Number Publication Date
IE831098L IE831098L (en) 1983-11-14
IE55519B1 true IE55519B1 (en) 1990-10-10

Family

ID=27008080

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1098/83A IE55519B1 (en) 1982-05-14 1983-05-12 Use of a protoberberine alkaloid and composition containing same

Country Status (11)

Country Link
EP (1) EP0108147B1 (enExample)
AU (1) AU571184B2 (enExample)
CA (1) CA1220139A (enExample)
DE (1) DE3377695D1 (enExample)
ES (1) ES8703871A1 (enExample)
GR (1) GR79223B (enExample)
IE (1) IE55519B1 (enExample)
IL (1) IL68690A0 (enExample)
IT (1) IT1173712B (enExample)
PT (1) PT76690B (enExample)
WO (1) WO1983003970A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100258849B1 (ko) * 1998-04-24 2000-08-01 박원배 약학적으로 유용한 프로토베르베린염 유도체 및프로토베르베린유도체와 이의 염
WO2003047505A2 (en) 2001-11-14 2003-06-12 Rutgers, The State University Topoisomerase poison agents
EP1453507B1 (en) 2001-11-14 2009-03-04 Rutgers, The State University Solubilized topoisomerase poison agents
ES2311639T3 (es) 2001-11-14 2009-02-16 Rutgers, The State University Agentes citotoxicos.
WO2003041660A2 (en) 2001-11-14 2003-05-22 Rutgers, The State University Solubilized topoisomerase poisons
US6992088B2 (en) 2002-08-09 2006-01-31 Rutgers, The State University Of New Jersey Nitro and amino substituted heterocycles as topoisomerase I targeting agents
AU2003268075A1 (en) 2002-08-09 2004-02-25 Edmond J. Lavoie Nitro and amino substituted dibenzonaphthyridines as topoisomerase agents
WO2004014918A1 (en) 2002-08-09 2004-02-19 Rutgers, The State University Nitro and amino substituted topoisomerase agents
EP1562593B1 (en) 2002-11-12 2014-07-16 Rutgers, The State University of New Jersey Topoisomerase-targeting agents
CN100441183C (zh) * 2005-08-29 2008-12-10 中国医学科学院皮肤病研究所 盐酸13-己基小檗碱和盐酸13-己基巴马汀制备治疗湿疹、皮炎和银屑病的药物用途
WO2010102219A1 (en) 2009-03-06 2010-09-10 Rutgers, The State University Of New Jersey Methylenedioxybenzo [i] phenanthridine derivatives used to treat cancer
EP2405755A4 (en) * 2009-03-11 2012-11-28 Xintria Pharmaceutical Corp Inc METHOD AND COMPOSITIONS FOR TREATING METABOLISM AND CARDIOVASCULAR DISEASES
WO2010127363A1 (en) 2009-05-01 2010-11-04 Rutgers, The State University Of New Jersey Toposiomerase inhibitors
US20140107505A1 (en) 2012-10-11 2014-04-17 Alon Marmor Determination of ventricular pressure and related values
EP3442979A4 (en) 2016-04-04 2019-12-18 Rutgers, the State University of New Jersey topoisomerase poisons

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL129028C (enExample) * 1964-02-13
US3420834A (en) * 1964-11-13 1969-01-07 Roussel Uclaf 2,3-dimethoxy-berbines substituted in the 10 position and process
JPS4942700A (enExample) * 1972-08-25 1974-04-22
US3920665A (en) * 1972-10-19 1975-11-18 Kanebo Ltd Berbine compounds
JPS523397B2 (enExample) * 1972-11-20 1977-01-27
US3910938A (en) * 1973-01-27 1975-10-07 Kanebo Ltd Berbine derivatives
US4042592A (en) * 1974-05-08 1977-08-16 Kanebo, Ltd. Novel dibenzo[a,g]quinolizinium compounds
US4087426A (en) * 1976-08-16 1978-05-02 Research Corporation Oxybisberberine and a process for its production
SE426548B (sv) * 1978-12-05 1983-01-31 Haessle Ab Fast farmaceutisk beredning innehallande en terapeutiskt effektiv hjertglykosid och en polymer

Also Published As

Publication number Publication date
CA1220139A (en) 1987-04-07
ES8703871A1 (es) 1987-03-16
GR79223B (enExample) 1984-10-22
AU1706383A (en) 1983-12-02
PT76690B (en) 1986-03-19
DE3377695D1 (en) 1988-09-22
ES522754A0 (es) 1987-03-16
AU571184B2 (en) 1988-04-14
IL68690A0 (en) 1983-09-30
EP0108147B1 (en) 1988-08-17
IT8348294A1 (it) 1984-11-13
IT8348294A0 (it) 1983-05-13
IE831098L (en) 1983-11-14
PT76690A (en) 1983-06-01
WO1983003970A1 (en) 1983-11-24
EP0108147A4 (en) 1984-09-13
IT1173712B (it) 1987-06-24
EP0108147A1 (en) 1984-05-16

Similar Documents

Publication Publication Date Title
US5153178A (en) Compositions and method of treatment for improving circulatory performance
US4761417A (en) Compounds, compositions and method of treatments for improving circulatory performance
EP0108147B1 (en) Use of a protoberberine alkaloid and composition containing same
Johnston et al. A comparative interaction of epinephrine with enflurane, isoflurane, and halothane in man
SUNG et al. Intravenous verapamil for termination of re-entrant supraventricular tachycardias: intracardiac studies correlated with plasma verapamil concentrations
KR101653071B1 (ko) 선별적 ｓ1ｐ₁ 수용체 작동약에 대한 투약 섭생
JPH09505809A (ja) ヒドロキシカルバゾール化合物類による平滑筋移動および増殖の阻害
Pollick et al. The cardiac effects of d-and l-disopyramide in normal subjects: a noninvasive study.
TWI336254B (en) Pharmaceutical composition for treating abdominal discomfort
US4749708A (en) Composition for improving circulatory performance
JPS61145121A (ja) ジペプタイド誘導体を含有する、筋萎縮性側索硬化症を治療するための薬剤
TW589184B (en) Pharmaceutical composition for preventing or reversing diabetic cardiomyopathy
Wolfson et al. Treatment of cardiac arrhythmias with beta-adrenergic blocking agents: Clinical and experimental studies
Wing et al. The effect of metoclopramide and atropine on the absorption of orally administered mexiletine
van der Giessen et al. Acute hemodynamic effects of nisoldipine and pimobendan in conscious pigs with chronic heart failure
Warner Beta-adrenergic blocking agents and anaesthesia: a review
Aronson et al. Effects of fenoldopam on renal blood flow and systemic hemodynamics during isoilurane anesthesia
DE69903546T2 (de) Levosimendan für die behandlung von pulmonaler hypertonie
KR0136787B1 (ko) 심장질환 치료에 쓰이는 프로파페논과 퀴니딘의 지속성 조성물
DE60217336T2 (de) Verwendung eines pyridazinon derivates zur behandlung des kongestiven herzversagens
Kambara et al. Effects of intravenous administration of nicorandil on cardiovascular hemodynamics and left ventricular function
Hitoshi et al. Vasodilating effect of crude platycodin in anesthetized dogs
DE60016038T2 (de) Neue verwendung von levosimendan
JPH01216923A (ja) プロスタグランジン類の選択的作用増強剤
Alpert et al. Chemistry, pharmacology, antiarrhythmic efficacy and adverse effects of tocainide hydrochloride, an orally active structural analog of lidocaine

Legal Events

Date Code Title Description
MM4A Patent lapsed